Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia

2 Visninger
administrator
administrator
08/04/23

In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.

  • Kategori

Vis mere

0 Kommentarer Sorter efter

Ingen kommentarer fundet

Facebook kommentarer

Næste